Opportunity Information: Apply for CDC RFA GH11 1172
Apply for CDC RFA GH11 1172
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening the Capacity of the Dominican Republic to Provide HIV/STI/TB Prevention and Risk Reduction Among Drug Users under the President s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 1, 2011 and posted on Mar 1, 2011.
- Applicants must submit their applications by Apr 28, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $900,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Special district governments Small businesses County governments Private institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments.
- Eligible applicants that can apply for this funding opportunity are Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Non domestic (non U.S.) entity Other (specify) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Strengthening the Capacity of the Dominican Republic to Provide HIV/STI/TB Prevention and Risk Reduction Among Drug Users under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a CDC-funded cooperative agreement designed to expand and improve public health services for people who use drugs in the Dominican Republic, with a particular emphasis on HIV prevention while also addressing related sexually transmitted infections (STIs) and tuberculosis (TB). The overall focus is on reaching people who are actively using drugs, including people who inject drugs, and especially those who are not currently enrolled in drug dependence treatment programs. It recognizes that this population can face overlapping risks, including transactional sex and male-to-male sexual activity, and it aims to reduce infection risk by increasing access to proven prevention services and strengthening how those services are delivered, monitored, and sustained.
A central objective of the program is to implement evidence-based prevention strategies that meaningfully increase coverage, access, delivery, and intensity of services for drug users (DUs) and injecting drug users (IDUs). In practical terms, this means supporting interventions with demonstrated effectiveness and scaling them so that more people in high-risk networks are actually reached, engaged, and retained in prevention services. The opportunity explicitly includes drug users who also engage in other high-risk behaviors, such as sex work or men who have sex with men, reflecting an intent to tailor outreach and prevention packages to real-world patterns of risk rather than treating drug use as an isolated issue. The emphasis on "intensity" suggests that programs should not only make brief contact with clients, but deliver a level of service sufficient to influence behavior, improve safer practices, and connect people to care when needed.
Another major component is building quality assurance and strong monitoring and evaluation systems specifically for prevention services targeting DUs and IDUs. This part of the opportunity is about making sure the services provided are consistent, effective, and measurable, and that implementers can track what is being delivered, to whom, and with what outcomes. It implies creating or strengthening program standards, routine data collection processes, performance monitoring, and feedback loops that allow programs to improve over time. This quality and evaluation focus also supports accountability, helping ensure that prevention activities are not only implemented, but implemented well, with reliable evidence of reach and impact.
The grant also places heavy importance on coordination and leadership across both government and civil society. Recipients are expected to participate in and support national and local coordination efforts so that program implementation aligns with the Dominican Republic's National HIV Prevention Plan for Drug Users. That alignment requirement signals that the award is not meant to operate as a standalone project, but as part of a broader national response where ministries, local organizations, and community stakeholders work together, share information, and avoid duplicating efforts. The coordination element also suggests supporting planning and decision-making structures that help integrate services across sectors, which is often critical for reaching drug-using populations who may be disconnected from traditional healthcare settings.
Capacity building is the fourth pillar of the program, and it targets both local community-based organizations and the Ministry of Health. The intent is to strengthen the ability of local institutions to adapt and implement a comprehensive package of HIV prevention, care, and treatment services for a growing population of people who use drugs. Capacity building here can reasonably be understood as developing local skills, systems, and operational readiness so that effective services can be maintained beyond the life of a single award cycle. The language about adapting and implementing a comprehensive package indicates a desire for integrated services, not just prevention messaging, but also pathways into testing, linkage to care, and treatment support as appropriate, with special attention to those who remain outside formal drug treatment programs.
From an administrative standpoint, this opportunity (Funding Opportunity Number CDC-RFA-GH11-1172) was offered as a discretionary award using a cooperative agreement mechanism, meaning the CDC would typically expect substantial involvement in the funded activities compared with a standard grant. It falls under the health funding activity category and is associated with CFDA 93.067 (Global AIDS). The posting date was March 1, 2011, with an original and final closing date of April 28, 2011, and it was archived May 28, 2011, indicating it is a historical funding opportunity rather than an open competition today.
The funding profile indicates an estimated total program funding of $900,000, with an expected single award. The award ceiling was $300,000 and the award floor was $200,000, framing the likely annual or project-period funding range per recipient depending on CDC structure and performance expectations. There was no cost-sharing or matching requirement, which reduces barriers for organizations that may have strong program capacity but limited ability to provide non-federal funds.
Eligibility was intentionally broad, allowing a wide range of potential applicants, including nonprofit organizations (both with and without 501(c)(3) status), for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, and U.S. state/local/territorial governments or their bona fide agents. The opportunity also allowed non-U.S. (non-domestic) entities to apply, which is consistent with the international focus on service delivery and capacity building in the Dominican Republic. Applicants applying as a bona fide agent for a state or local government were required to provide formal documentation (a letter) confirming that status as part of the application package.
Overall, the opportunity is best understood as a targeted PEPFAR-supported effort to strengthen the Dominican Republic's ability to prevent HIV and related infections among drug-using populations by expanding proven prevention services, ensuring those services meet quality standards and are tracked with solid monitoring and evaluation, reinforcing national coordination and leadership, and building local organizational and government capacity to deliver a comprehensive continuum of prevention and care, particularly for active drug users not already engaged in drug dependence treatment.
Frequently Asked Questions (FAQs)
1. What is the purpose of this grant opportunity?
This CDC-funded cooperative agreement is designed to strengthen the Dominican Republic's capacity to deliver HIV prevention and risk-reduction services for people who use drugs, including people who inject drugs. It also addresses related sexually transmitted infections (STIs) and tuberculosis (TB) as part of a broader public health response supported by PEPFAR.
2. What is the official title of the opportunity?
The opportunity is titled "Strengthening the Capacity of the Dominican Republic to Provide HIV/STI/TB Prevention and Risk Reduction Among Drug Users under the President's Emergency Plan for AIDS Relief (PEPFAR)."
3. What is the Funding Opportunity Number (FOA/NOFO number)?
The Funding Opportunity Number is CDC-RFA-GH11-1172.
4. Who is the funder and what type of award is this?
The funder is the U.S. Centers for Disease Control and Prevention (CDC). The mechanism is a cooperative agreement, which typically means CDC expects substantial involvement in funded activities compared with a standard grant.
5. What program or CFDA is associated with this opportunity?
This opportunity is associated with CFDA 93.067 (Global AIDS).
6. Is this opportunity currently open?
No. The opportunity is archived and is presented as a historical funding opportunity rather than an active competition.
7. What were the posting and closing dates?
The posting date was March 1, 2011. The original and final closing date was April 28, 2011. The opportunity was archived on May 28, 2011.
8. What population is the program focused on?
The program focuses on people who are actively using drugs in the Dominican Republic, including injecting drug users (IDUs), with special emphasis on reaching those who are not currently enrolled in drug dependence treatment programs.
9. Does the program address overlapping risk behaviors?
Yes. The opportunity recognizes that people who use drugs may face overlapping risks, including transactional sex and male-to-male sexual activity. The intent is to tailor outreach and prevention approaches to real-world patterns of risk rather than treating drug use as an isolated issue.
10. What kinds of services or strategies are emphasized?
The opportunity emphasizes implementing evidence-based prevention strategies that increase coverage, access, delivery, and intensity of services for drug users and injecting drug users. It is focused on scaling interventions with demonstrated effectiveness so more people in high-risk networks are reached, engaged, and retained in services.
11. What does "increasing intensity" of services mean in this context?
Based on the description, "intensity" suggests the program aims for more than brief contact with clients. It implies delivering a sufficient level of service to influence behavior, improve safer practices, and connect people to care when needed.
12. Beyond HIV, what other health issues are included?
In addition to HIV prevention, the program also addresses sexually transmitted infections (STIs) and tuberculosis (TB) as related public health priorities for the target population.
13. What role do monitoring, evaluation, and quality assurance play?
A major component is building quality assurance and strong monitoring and evaluation systems specifically for prevention services targeting drug users and injecting drug users. This includes strengthening program standards, routine data collection, performance monitoring, and feedback loops so services are consistent, effective, measurable, and improve over time.
14. Why is coordination and leadership emphasized?
The opportunity places heavy importance on coordination and leadership across government and civil society so implementation aligns with the Dominican Republic's National HIV Prevention Plan for Drug Users. This indicates the award is intended to contribute to a broader national response, support planning and decision-making structures, and help avoid duplication of effort.
15. What is meant by alignment with the National HIV Prevention Plan for Drug Users?
Recipients are expected to participate in and support national and local coordination efforts so that funded activities fit within, and support, the Dominican Republic's National HIV Prevention Plan for Drug Users rather than operating as a standalone project.
16. What does capacity building include under this program?
Capacity building is a core pillar and targets both local community-based organizations and the Ministry of Health. The intent is to strengthen local skills and systems to adapt and implement a comprehensive package of HIV prevention, care, and treatment services for a growing population of people who use drugs, including those outside formal drug treatment programs.
17. What does a "comprehensive package" of services imply?
From the description provided, a comprehensive package indicates integrated services that go beyond prevention messaging and include pathways into testing, linkage to care, and treatment support as appropriate.
18. What is the total estimated funding and how many awards were expected?
The estimated total program funding was $900,000, and a single award was expected.
19. What were the award ceiling and award floor?
The award ceiling was $300,000 and the award floor was $200,000.
20. Was cost sharing or matching required?
No. The opportunity stated there was no cost-sharing or matching requirement.
21. Who was eligible to apply?
Eligibility was broad and included nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, and U.S. state/local/territorial governments or their bona fide agents.
22. Could non-U.S. (non-domestic) organizations apply?
Yes. The opportunity allowed non-U.S. (non-domestic) entities to apply, consistent with the international focus on strengthening services in the Dominican Republic.
23. What is a "bona fide agent" and was documentation required?
The opportunity allowed applicants to apply as a bona fide agent for a state or local government, but required formal documentation confirming that status. Specifically, a letter confirming bona fide agent status needed to be included as part of the application package.
24. What is the main goal in terms of sustainability?
The capacity-building focus indicates an emphasis on strengthening local institutions and government systems so effective prevention and related services can be maintained beyond a single award cycle.
Browse more opportunities from the same category: Health
Next opportunity: Demographic Surveillance Study Support in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Formative Assessment of HIV Risk and Size Estimation Among Most At Risk Populations (MARPs) and Integrated Biological and Behavioral Surveillance Among MARPs in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1172
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1172) also looked into and applied for these:
| Funding Opportunity |
|---|
| Demographic Surveillance Study Support in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11101 Funding Number: CDC RFA GH11 11101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Technical Assistance To The Ministry Of Health (MOH) For HIV Services And Program Transition In The Republic Of Mozambique Under The President s Emergency Plan For AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11108 Funding Number: CDC RFA GH11 11108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Direction Nationale de lEau Potable et de lAssainissement (DINEPA) Apply for CDC RFA GH11 11105 Funding Number: CDC RFA GH11 11105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition Revision for Resuscitation Outcomes Center Randomized Clinical Trial (U01) Apply for RFA HL 11 036 Funding Number: RFA HL 11 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP11 1103 Funding Number: CDC RFA IP11 1103 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 11 004 Funding Number: RFA NS 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| FY 2011 Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 11 004 Funding Number: SM 11 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $360,000 |
| Strengthening the Capacity of Local Indigenous Faith Based Partners in Zambia to Provide HIV/AIDS Prevention, Treatment and Care Services in a Comprehensive and Sustainable Manner under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1120 Funding Number: CDC RFA GH11 1120 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Partnerships for Biodefense (R01) Apply for RFA AI 11 014 Funding Number: RFA AI 11 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R01) Apply for PA 11 138 Funding Number: PA 11 138 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Economics of Retirement (R03) Apply for PA 11 139 Funding Number: PA 11 139 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Economics of Retirement (R21) Apply for PA 11 140 Funding Number: PA 11 140 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Cooperative Agreement with the South Africa National Health Laboratory Service (NHLS) Apply for CDC RFA GH11 1199 Funding Number: CDC RFA GH11 1199 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Part D Coordinated HIV Services and Access to Research for WICY One Time Supplemental Funds Apply for HRSA 11 094 Funding Number: HRSA 11 094 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Apply for CDC RFA TS11 1102PPHF11 Funding Number: CDC RFA TS11 1102PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Competitive Revision Applications for NIDCR funded Cooperative Agreements (U01) Apply for PAR 11 144 Funding Number: PAR 11 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Centers for Excellence in Clinical Preventive Services (P01) Apply for RFA HS 11 005 Funding Number: RFA HS 11 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| The Infant Immune System Implications for Vaccines and Response to Infections (R01) Apply for RFA AI 11 010 Funding Number: RFA AI 11 010 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| International Research in Infectious Diseases, including AIDS (R01) Apply for PAR 11 145 Funding Number: PAR 11 145 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers for Education and Research on Therapeutics (CERTs) Scientific Forum (U19) Apply for RFA HS 11 003 Funding Number: RFA HS 11 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1172", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.